Thomas Zehnder

Thomas has over 20 years of experience in the medtech and healthcare industries as both a senior healthcare executive and an entrepreneur. Some of the most prominent companies he has worked for include corporate firms, Sulzer Medica, Covance and Stratec Medical, as well as venture capital-backed medtech startups, Spinelab and Intelligent Medical Implants. From 2007 to 2014, Thomas was CEO of Spinelab, a startup specializing in developing motion-preserving stabilization systems for the spine. During his tenure as CEO, he raised over US$ 22 million in venture funding and co-invented seven patents. A serial entrepreneur, Thomas also founded and co-founded four healthcare companies, Akross, Spinelab, AMYRA Biotech and Actimplant. Since 2014, he has been a general partner at BlueOcean Ventures in Geneva and a member of the board of directors for AMYRA Biotech, IOLUTION Holding, Actimplant and Rheon Medical. Thomas is also an observer on the Ava board. Thomas holds a MSc from the Swiss Institute of Technology (ETH) in Zurich and a Doctorate in Business Administration / Technology Management from the University of St. Gall HSG.